Skip to main navigation Skip to search Skip to main content

Comparing and combining the therapeutic effects of Cynata MSCs with a clinically-used corticosteroid in a murine model of chronic allergic airways disease

  • Samuel, Chrishan (Primary Chief Investigator (PCI))
  • Royce, Simon (Chief Investigator (CI))

Project: Research

Project Details

Project Description

Contract research (funded by Cynata Therapeutics Ltd; Armadale, Victoria) to determine the efficacy of Cynata-mesenchymal stem cells (MSCs) as a novel treatment for asthma, in comparison to or combined with a clinically-used corticosteroid (representing current standard of care for asthmatics).
Short titleEvaluting the efficacy of Cynata-MSCs as a novel therapy for asthma
StatusFinished
Effective start/end date1/02/17 → 31/01/18

Keywords

  • Asthma
  • Allergic airways disease
  • Airway remodelling
  • Fibrosis
  • Stem Cells
  • Corticosteroids